Lenz Therapeutics to Present at Investor and Medical Conferences
25 Aug 2025 //
GLOBENEWSWIRE
LENZ Therapeutics’s Vizz Receives Approval in US
31 Jul 2025 //
FDA
LENZ Therapeutics Gets FDA Approval for Presbyopia Treatment VIZZ
31 Jul 2025 //
GLOBENEWSWIRE
LENZ Therapeutics Submits NDA for LNZ100 to NMPA in China
28 Jul 2025 //
GLOBENEWSWIRE
Lenz Therapeutics & Lab Théa Ink Exclusive Deal for Lnz100
07 Jul 2025 //
GLOBENEWSWIRE
Lenz Therapeutics to Present at Upcoming Investor Conferences
27 May 2025 //
GLOBENEWSWIRE
LENZ Announces Topline Data from PhII Trial of LNZ100 & LNZ101
18 Oct 2022 //
BUSINESSWIRE